These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21859459)

  • 1. Response by sex to statin plus ezetimibe or statin monotherapy: a pooled analysis of 22,231 hyperlipidemic patients.
    Abramson BL; Benlian P; Hanson ME; Lin J; Shah A; Tershakovec AM
    Lipids Health Dis; 2011 Aug; 10():146. PubMed ID: 21859459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 subjects from 27 clinical trials.
    Morrone D; Weintraub WS; Toth PP; Hanson ME; Lowe RS; Lin J; Shah AK; Tershakovec AM
    Atherosclerosis; 2012 Aug; 223(2):251-61. PubMed ID: 22410123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
    Ose L; Shah A; Davies MJ; Rotonda J; Maccubbin D; Tribble D; Veltri E; Mitchel Y
    Curr Med Res Opin; 2006 May; 22(5):823-35. PubMed ID: 16709304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical reality and challenges with familial hypercholesterolemia patients' management. 2024 results from the Regional Center for Rare Diseases (RCRD) Registry in Poland.
    Lewek J; Sosnowska B; Starostecka E; Konopka A; Gach A; Rutkowska L; Adach W; Mierczak K; Bielecka-Dąbrowa A; Banach M
    Int J Cardiol; 2025 Jan; 419():132667. PubMed ID: 39442759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia.
    Banach M; Duell PB; Gotto AM; Laufs U; Leiter LA; Mancini GBJ; Ray KK; Flaim J; Ye Z; Catapano AL
    JAMA Cardiol; 2020 Oct; 5(10):1124-1135. PubMed ID: 32609313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia.
    Izquierdo-Palomares JM; Fernandez-Tabera JM; Plana MN; Añino Alba A; Gómez Álvarez P; Fernandez-Esteban I; Saiz LC; Martin-Carrillo P; Pinar López Ó
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009462. PubMed ID: 27888640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recaticimab as Add-On Therapy to Statins for Nonfamilial Hypercholesterolemia: The Randomized, Phase 3 REMAIN-2 Trial.
    Sun Y; Lv Q; Guo Y; Wang Z; Huang R; Gao X; Han Y; Yao Z; Zheng M; Luo S; Li Y; Gu X; Zhang Y; Wang J; Hong L; Ma X; Su G; Sheng J; Lai C; Shen A; Wang M; Zhang W; Wu S; Zheng Z; Li J; Zhong T; Wang Y; He L; Du X; Ma CS
    J Am Coll Cardiol; 2024 Nov; 84(20):2037-2047. PubMed ID: 39505412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
    Bays HE; Davidson M; Jones MR; Abby SL
    Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral budesonide for induction of remission in ulcerative colitis.
    Sherlock ME; MacDonald JK; Griffiths AM; Steinhart AH; Seow CH
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD007698. PubMed ID: 26497719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD007807. PubMed ID: 32851663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Efficacy of Ezetimibe Combined with Rosuvastatin in the Treatment of Patients with Primary Hypercholesterolemia Inadequately Controlled by Statin Therapy.
    Wei Z; Wang F; Zhang L; Dai W
    Br J Hosp Med (Lond); 2024 Nov; 85(11):1-13. PubMed ID: 39618211
    [No Abstract]   [Full Text] [Related]  

  • 12. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD007807. PubMed ID: 28752910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.
    Rader DJ; Davidson MH; Caplan RJ; Pears JS
    Am J Cardiol; 2003 Mar; 91(5A):20C-23C; discussion 23C-24C. PubMed ID: 12646340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin monotherapy in the treatment of composite cardiovascular events with hypercholesterolemia: A meta-analysis.
    Liu L; Deng Y; Li L; Yang X; Yin Z; Lai Y
    PLoS One; 2024; 19(11):e0310696. PubMed ID: 39536001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achievement of LDL-C <55 mg/dL among US adults: Findings from the cvMOBIUS2 registry.
    Navar AM; Shah NP; Shrader P; Thomas LE; Ahmad Z; Allred C; Chamberlain AM; Chrischilles EA; Dhalwani N; Effron MB; Hayek S; Jones LK; Kalich B; Shapiro MD; Wójcik C; Peterson ED
    Am Heart J; 2025 Jan; 279():107-117. PubMed ID: 38972336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial.
    Gibson CM; Duffy D; Bahit MC; Chi G; White H; Korjian S; Alexander JH; Lincoff AM; Heise M; Kingwell BA; Nicolau JC; Lopes RD; Cornel JH; Lewis BS; Vinereanu D; Goodman SG; Bode C; Steg PG; Libby P; Sacks FM; Bainey KR; Ridker PM; Mahaffey KW; Aylward P; Nicholls SJ; Pocock SJ; Mehran R; Harrington RA;
    Eur Heart J; 2024 Dec; 45(47):5023-5038. PubMed ID: 39221651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of lipid-lowering treatment on indices of MASLD in familial hypercholesterolemia patients.
    Boutari C; Rizos CV; Liamis G; Skoumas I; Rallidis L; Garoufi A; Kolovou G; Sfikas G; Tziomalos K; Skalidis E; Kotsis V; Doumas M; Stamatelopoulos K; Lambadiari V; Anagnostis P; Boufidou A; Giannakopoulou V; Anastasiou G; Petkou E; Vlachopoulos C; Dima I; Fakas G; Papathanasiou KA; Attilakos A; Kolovou V; Koumaras C; Agapakis D; Zacharis E; Antza C; Milionis H; Liberopoulos E; Mantzoros CS
    Clin Nutr; 2024 Dec; 43(12):84-91. PubMed ID: 39437569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between Statin Use and Glaucoma in the All of Us Research Program.
    Lee SY; Paul ME; Coleman AL; Kitayama K; Yu F; Pan D; Tseng VL
    Ophthalmol Glaucoma; 2024; 7(6):563-571. PubMed ID: 39094953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation.
    Jayanti S; Beruni NA; Chui JN; Deng D; Liang A; Chong AS; Craig JC; Foster B; Howell M; Kim S; Mannon RB; Sapir-Pichhadze R; Scholes-Robertson NJ; Strauss AT; Jaure A; West L; Cooper TE; Wong G
    Cochrane Database Syst Rev; 2024 Dec; 12(12):CD014966. PubMed ID: 39698949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial.
    Vermeire S; Schreiber S; Rubin DT; D'Haens G; Reinisch W; Watanabe M; Mehta R; Roblin X; Beales I; Gietka P; Hibi T; Hospodarskyy I; Ritter T; Genovese MC; Kwon P; Santermans E; Le Brun FO; Barron R; Masior T; Danese S
    Lancet Gastroenterol Hepatol; 2024 Dec; ():. PubMed ID: 39637881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.